A detailed history of Ronald Blue Trust, Inc. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 1,434 shares of LNTH stock, worth $131,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,434
Previous 3,141 54.35%
Holding current value
$131,167
Previous $252,000 37.7%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$77.7 - $123.62 $132,633 - $211,019
-1,707 Reduced 54.35%
1,434 $157,000
Q2 2024

Jul 18, 2024

BUY
$58.87 - $83.05 $180,259 - $254,299
3,062 Added 3875.95%
3,141 $252,000
Q1 2024

May 01, 2024

BUY
$51.07 - $68.26 $1,991 - $2,662
39 Added 97.5%
79 $4,000
Q4 2023

Jan 18, 2024

BUY
$55.6 - $77.89 $1,167 - $1,635
21 Added 110.53%
40 $3,000
Q3 2023

Oct 11, 2023

BUY
$60.27 - $90.75 $1,145 - $1,724
19 New
19 $2,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.29B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.